Suchergebnisse - "Kayser, Sabine"

PubPharm (5)

1

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia : results of the AML Study Group (AMLSG)

enthalten in: Blood | 2013

von Gaidzik, V. | Schlenk, R. | Paschka, P. | +27

2

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

enthalten in: Blood | 2011

von Kayser, S. | Döhner, K. | Krauter, J. | +18

3

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Paschka, P. | Schlenk, R. | Gaidzik, V. | +11

4

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Gröschel, S. | Lugthart, S. | Schlenk, R. | +17

5

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

enthalten in: Haematologica | 2009

von Schlenk, R. | Döhner, K. | Kneba, M. | +28

CommentIn: Haematologica. 2009 Jan;94(1):10-6. - PMID 19118375

1
[1]